Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Habermann

Showing results (71-80 of 374) with videos related to

Pageof 38
Sort By:
Leukemia & Lymphoma|February 10, 2010
18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reportsAlexandra Thomas, Roger D Gingrich, Brian J Smith, et al.
The Annals of Thoracic Surgery|October 23, 2012
Endobronchial ultrasound and lymphoproliferative disorders: a retrospective studySeher Iqbal, Zachary S DePew, Paul J Kurtin, et al.
Haematologica|October 10, 2024
CODOX-M/IVAC-R <i>versus</i> DA-EPOCH-R in double-hit/triple-hit lymphoma patients aged 60 years or underSuheil Albert Atallah-Yunes, Matthew J Rees, Thomas E Witzig, et al.
Nutrition and Cancer|September 21, 2018
Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?Gita Thanarajasingam, Matthew J Maurer, Thomas M Habermann, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|May 26, 2007
A prospective study of the relationship between medical knowledge and professionalism among internal medicine residentsColin P West, Jefrey L Huntington, Mashele M Huschka, et al.
International Journal of Dermatology|July 8, 2017
Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphomaTimothy W Chang, Amy L Weaver, Tait D Shanafelt, et al.
Leukemia & Lymphoma|June 22, 2013
Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)Kristen Ganjoo, Fangxin Hong, Sandra J Horning, et al.
Retina (Philadelphia, Pa.)|December 20, 2014
Paraneoplastic sarcoid-like reactions and the eyeSaranya C Balasubramaniam, Diva R Salomão, John B Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 StudyHoward Hochster, Edie Weller, Randy D Gascoyne, et al.
American Journal of Epidemiology|September 13, 2002
Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective studyJames R Cerhan, Carol A Janney, Celine M Vachon, et al.
Pageof 38

Showing results (71-80 of 374) with videos related to

Sort By:
Pageof 38
Leukemia & Lymphoma|February 10, 2010
18-Fluoro-deoxyglucose positron emission tomography report interpretation as predictor of outcome in diffuse large B-cell lymphoma including analysis of 'indeterminate' reportsAlexandra Thomas, Roger D Gingrich, Brian J Smith, et al.
The Annals of Thoracic Surgery|October 23, 2012
Endobronchial ultrasound and lymphoproliferative disorders: a retrospective studySeher Iqbal, Zachary S DePew, Paul J Kurtin, et al.
Haematologica|October 10, 2024
CODOX-M/IVAC-R <i>versus</i> DA-EPOCH-R in double-hit/triple-hit lymphoma patients aged 60 years or underSuheil Albert Atallah-Yunes, Matthew J Rees, Thomas E Witzig, et al.
Nutrition and Cancer|September 21, 2018
Low Plasma Omega-3 Fatty Acid Levels May Predict Inferior Prognosis in Untreated Diffuse Large B-Cell Lymphoma: A New Modifiable Dietary Biomarker?Gita Thanarajasingam, Matthew J Maurer, Thomas M Habermann, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|May 26, 2007
A prospective study of the relationship between medical knowledge and professionalism among internal medicine residentsColin P West, Jefrey L Huntington, Mashele M Huschka, et al.
International Journal of Dermatology|July 8, 2017
Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphomaTimothy W Chang, Amy L Weaver, Tait D Shanafelt, et al.
Leukemia & Lymphoma|June 22, 2013
Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)Kristen Ganjoo, Fangxin Hong, Sandra J Horning, et al.
Retina (Philadelphia, Pa.)|December 20, 2014
Paraneoplastic sarcoid-like reactions and the eyeSaranya C Balasubramaniam, Diva R Salomão, John B Davies, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2009
Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: results of the randomized phase III ECOG1496 StudyHoward Hochster, Edie Weller, Randy D Gascoyne, et al.
American Journal of Epidemiology|September 13, 2002
Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective studyJames R Cerhan, Carol A Janney, Celine M Vachon, et al.
Pageof 38